Multimodal Breast Cancer Tx May Up Cytokines, Comorbidities

Share this content:
Multimodal Breast Cancer Tx May Up Cytokines, Comorbidities
Multimodal Breast Cancer Tx May Up Cytokines, Comorbidities

MONDAY, Dec. 5, 2016 (HealthDay News) -- Breast cancer survivors who undergo multimodal treatment have higher cytokines and comorbidities than controls without cancer, according to a study published online Nov. 28 in the Journal of Clinical Oncology.

Catherine M. Alfano, Ph.D., from the American Cancer Society in Washington, D.C., and colleagues conducted a longitudinal study to examine proinflammatory cytokines and comorbidity development over time in 315 women (209 breast cancer survivors and 106 noncancer controls). Participants completed a baseline questionnaire, interview, and blood draw at the time of breast cancer work-up; measures were repeated six and 18 months after primary cancer treatment or within a comparable time frame for the cancer survivors and controls, respectively.

The researchers found that survivors and controls had no baseline differences in comorbidities or cytokines. Compared with the control group, breast cancer survivors had significantly higher tumor necrosis factor-α and interleukin-6 over time. Compared with controls, survivors treated with surgery, radiation, and chemotherapy accumulated a significantly greater burden of comorbid conditions and suffered greater inflammation-associated pain over time after cancer treatment.

"Survivors who had multimodal treatment had higher cytokines and comorbidities, suggestive of accelerated aging," the authors write. "Given that many comorbidities take years to develop, future research with extended follow-up beyond 18 months is necessary to examine the evidence of accelerated aging in cancer survivors and to determine the responsible mechanisms."

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Basivertebral Nerve Ablation Beneficial for Chronic Back Pain

Basivertebral Nerve Ablation Beneficial for Chronic Back Pain

Improvement in self-reported outcomes at three months in patients with chronic lumbar back pain

FDA Approves Trulance for Chronic Idiopathic Constipation

FDA Approves Trulance for Chronic Idiopathic Constipation

Drug designed to stimulate secretion of intestinal fluid

ECG Could Be Used As Password for E-Health Record Access

ECG Could Be Used As Password for E-Health ...

Researchers say heartbeat could serve as a secure 'password' for patient's electronic medical history

is free, fast, and customized just for you!

Already a member?

Sign In Now »